Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 3
1992 1
2010 1
2012 2
2013 1
2014 1
2015 1
2016 1
2018 1
2019 1
2020 1
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

12 results

Results by year

Filters applied: . Clear all
Page 1
How do cardiologists select patients for dual antiplatelet therapy continuation beyond 1 year after a myocardial infarction? Insights from the EYESHOT Post-MI Study.
De Luca L, Colivicchi F, Meessen J, Uguccioni M, Piscione F, Bernabò P, Lardieri G, Granatelli A, Gabrielli D, Gulizia MM; EYESHOT Post-MI Investigators. De Luca L, et al. Clin Cardiol. 2019 Nov;42(11):1113-1120. doi: 10.1002/clc.23262. Epub 2019 Aug 31. Clin Cardiol. 2019. PMID: 31471975 Free PMC article.
[Service strategy for the early referral to catheterization laboratory of patients admitted with non-ST-elevation acute coronary syndromes in spoke hospitals: 5-year results of the Reggio Emilia province network].
Mantovani F, Guiducci V, Colaiori I, Pignatelli G, Manca F, Guerri E, Calzolari M, Catellani E, Reverzani A, Navazio A. Mantovani F, et al. Among authors: reverzani a. G Ital Cardiol (Rome). 2020 Oct;21(10):807-815. doi: 10.1714/3431.34207. G Ital Cardiol (Rome). 2020. PMID: 32968318 Italian.
Current presentation and management of 7148 patients with atrial fibrillation in cardiology and internal medicine hospital centers: the ATA AF study.
Di Pasquale G, Mathieu G, Maggioni AP, Fabbri G, Lucci D, Vescovo G, Pirelli S, Chiarella F, Scherillo M, Gulizia MM, Gussoni G, Colombo F, Panuccio D, Nozzoli C, Berisso MZ; ATA-AF Investigators. Di Pasquale G, et al. Int J Cardiol. 2013 Sep 10;167(6):2895-903. doi: 10.1016/j.ijcard.2012.07.019. Epub 2012 Aug 11. Int J Cardiol. 2013. PMID: 22884698
Antiarrhythmic strategies in patients with atrial fibrillation managed by cardiologists and internists: Antithrombotic Agents in Atrial Fibrillation (ATA-AF) survey.
Berisso MZ, Fabbri G, Gonzini L, Caruso D, Fontanella A, Pellegrini F, Silvestri N, Vincenti A, Mathieu G, Di Pasquale G; ATA-AF Investigators. Berisso MZ, et al. J Cardiovasc Med (Hagerstown). 2014 Aug;15(8):626-35. doi: 10.2459/JCM.0000000000000110. J Cardiovasc Med (Hagerstown). 2014. PMID: 24978662
Timing of events in STEMI patients treated with immediate PCI or standard medical therapy: implications on optimisation of timing of treatment from the CARESS-in-AMI trial.
Dimopoulos K, Dudek D, Piscione F, Mielecki W, Savonitto S, Borgia F, Murena E, Manari A, Gaspardone A, Ochala A, Zmudka K, Bolognese L, Steg PG, Flather M, Di Mario C; CARESS-in-AMI (Combined Abciximab RE-teplase Stent Study in Acute Myocardial Infarction) Investigators. Dimopoulos K, et al. Int J Cardiol. 2012 Feb 9;154(3):275-81. doi: 10.1016/j.ijcard.2010.09.042. Epub 2010 Oct 20. Int J Cardiol. 2012. PMID: 20961633 Clinical Trial.
12 results